Sterling Global Strategies Has Trimmed Amgen (AMGN) Stake By $35.78 Million, 4 Analysts Are Bullish Limoneira Company (LMNR) Last Week

July 26, 2017 - By Darrin Black

Sterling Global Strategies Llc decreased Amgen Inc (AMGN) stake by 99.4% reported in 2016Q4 SEC filing. Sterling Global Strategies Llc sold 245,067 shares as Amgen Inc (AMGN)’s stock declined 9.68%. The Sterling Global Strategies Llc holds 1,478 shares with $216,000 value, down from 246,545 last quarter. Amgen Inc now has $128.94B valuation. The stock declined 2.98% or $5.4 reaching $175.49 per share. About 2.88 million shares traded. Amgen, Inc. (NASDAQ:AMGN) has risen 5.27% since July 26, 2016 and is uptrending. It has underperformed by 11.43% the S&P500.

Among 4 analysts covering Limoneira (NASDAQ:LMNR), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Limoneira had 5 analyst reports since September 10, 2015 according to SRatingsIntel. Roth Capital maintained Limoneira Company (NASDAQ:LMNR) on Wednesday, June 7 with “Buy” rating. The firm has “Buy” rating given on Thursday, September 10 by TH Capital. Buckingham Research initiated the shares of LMNR in report on Monday, October 19 with “Buy” rating. The firm has “Buy” rating by Roth Capital given on Thursday, September 10. The stock has “Buy” rating by Lake Street on Wednesday, January 11. See Limoneira Company (NASDAQ:LMNR) latest ratings:

07/06/2017 Broker: Roth Capital Rating: Buy New Target: $26.5000 Maintain

Since March 15, 2017, it had 0 insider purchases, and 5 sales for $171,938 activity. Shares for $30,555 were sold by Michaelis Ronald L on Monday, April 3. Shares for $21,000 were sold by CHESS ELIZABETH BLANCHARD on Monday, April 3.

About 5,853 shares traded. Limoneira Company (NASDAQ:LMNR) has risen 20.88% since July 26, 2016 and is uptrending. It has outperformed by 4.18% the S&P500.

Limoneira Company is engaged in agribusiness and real estate development. The company has market cap of $330.34 million. The Company’s activities consist of fruit production, sales and marketing, rental operations, real estate development and capital investment activities. It has a 29.5 P/E ratio. The Company’s divisions include lemon operations, other agribusiness, rental activities and real estate development.

Investors sentiment decreased to 1.3 in 2016 Q4. Its down 0.57, from 1.87 in 2016Q3. It turned negative, as 6 investors sold Limoneira Company shares while 17 reduced holdings. 9 funds opened positions while 21 raised stakes. 3.25 million shares or 3.67% more from 3.13 million shares in 2016Q3 were reported. American Gru stated it has 0% of its portfolio in Limoneira Company (NASDAQ:LMNR). State Street accumulated 0% or 165,700 shares. Deutsche Bancorp Ag holds 0% of its portfolio in Limoneira Company (NASDAQ:LMNR) for 22,682 shares. Wells Fargo & Communication Mn stated it has 7,926 shares. Moreover, California State Teachers Retirement has 0% invested in Limoneira Company (NASDAQ:LMNR). Northern Trust invested in 0% or 135,573 shares. Deprince Race Zollo reported 0.03% of its portfolio in Limoneira Company (NASDAQ:LMNR). First Interstate State Bank invested 0.11% of its portfolio in Limoneira Company (NASDAQ:LMNR). Manufacturers Life Ins The accumulated 575 shares. Everett Harris Co Ca holds 69,895 shares. Teton holds 112,120 shares. Bnp Paribas Arbitrage Sa stated it has 103 shares. Retail Bank Of America De, North Carolina-based fund reported 23,613 shares. Citigroup Inc holds 0% or 8,140 shares. The California-based First Wilshire Secs Mgmt has invested 0.59% in Limoneira Company (NASDAQ:LMNR).

Among 21 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 10 Hold. Therefore 52% are positive. Amgen Inc. had 49 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Citigroup on Thursday, February 25. The stock has “Buy” rating by Mizuho on Friday, July 14. The firm has “Buy” rating given on Thursday, October 29 by UBS. Jefferies downgraded the shares of AMGN in report on Wednesday, April 5 to “Hold” rating. As per Tuesday, June 13, the company rating was maintained by Oppenheimer. The company was initiated on Friday, December 4 by Wells Fargo. The rating was initiated by Atlantic Securities with “Overweight” on Friday, December 18. Mizuho initiated Amgen, Inc. (NASDAQ:AMGN) on Tuesday, November 8 with “Buy” rating. The stock of Amgen, Inc. (NASDAQ:AMGN) has “Neutral” rating given on Wednesday, September 28 by Citigroup. The company was maintained on Monday, June 12 by Jefferies.

Since May 24, 2017, it had 0 insider purchases, and 2 sales for $1.02 million activity. $569,541 worth of Amgen, Inc. (NASDAQ:AMGN) was sold by BALTIMORE DAVID. Shares for $451,164 were sold by Patton Cynthia M on Wednesday, May 24.

Investors sentiment decreased to 1.09 in 2016 Q4. Its down 0.17, from 1.26 in 2016Q3. It dropped, as 98 investors sold AMGN shares while 488 reduced holdings. 111 funds opened positions while 527 raised stakes. 561.98 million shares or 1.23% less from 568.98 million shares in 2016Q3 were reported. Farmers Tru stated it has 28,890 shares or 1.46% of all its holdings. Bancorpsouth Inc holds 0.44% or 27,213 shares in its portfolio. St Johns Mgmt Ltd Llc has 8,076 shares for 0.98% of their portfolio. Bradley Foster & Sargent Ct holds 0.03% of its portfolio in Amgen, Inc. (NASDAQ:AMGN) for 5,250 shares. Hl Financial Limited Liability Corporation reported 0.16% stake. 2,418 are held by Mitchell Mcleod Pugh And Williams. Ny State Common Retirement Fund owns 0.46% invested in Amgen, Inc. (NASDAQ:AMGN) for 2.24 million shares. Spinnaker invested 0.18% in Amgen, Inc. (NASDAQ:AMGN). 1,415 were accumulated by Beech Hill Advsrs. Price T Rowe Associate Inc Md stated it has 0.1% of its portfolio in Amgen, Inc. (NASDAQ:AMGN). Bancshares Of The Ozarks holds 0.97% or 20,338 shares in its portfolio. 8,609 were reported by Sigma Planning. Alps accumulated 0% or 2,760 shares. Winfield reported 0.03% stake. Cim Investment Mangement Incorporated, a Pennsylvania-based fund reported 9,006 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts